Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy

被引:13
|
作者
Patel, V
Hedayati, SS
机构
[1] Vet Affairs N Texas Healthcare Syst, Div Nephrol, Dept Med, Dallas, TX 75216 USA
[2] Univ Texas, SW Med Ctr, Div Nephrol, Dept Med, Dallas, TX 75230 USA
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2006年 / 2卷 / 02期
关键词
highly active antiretroviral therapy; HIV; lactic acidosis; nucleoside reverse transcriptase inhibitor;
D O I
10.1038/ncpneph0102
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background A 51-year-old man with HIV infection on highly active antiretroviral therapy presented with abdominal pain and exertional dyspnea. Physical examination revealed increased respiration and cachexia. Laboratory tests showed a lactic acid concentration elevated to 6.4 mM. Investigation Physical examination, blood chemistry, arterial blood gas, urine analysis, chest X-ray, and ultrasound of liver. Diagnosis Nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis, hepatitis and chemical pancreatitis. Proximal renal tubular acidosis with Fanconi's syndrome, secondary to treatment with tenofovir. Management The patient was supported on intravenous and oral bicarbonate, riboflavin and phosphorus supplementation. Highly active antiretroviral therapy was discontinued. The patient's lactate level decreased about 2 weeks after discharge.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [1] Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy
    Vishal Patel
    S Susan Hedayati
    [J]. Nature Clinical Practice Nephrology, 2006, 2 : 109 - 114
  • [2] Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy
    Calza, L
    Manfredi, R
    Chiodo, F
    [J]. CLINICAL NUTRITION, 2005, 24 (01) : 5 - 15
  • [3] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
    Moore, RD
    Forney, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01): : 54 - 57
  • [4] Body composition in HIV-infected patients receiving highly active antiretroviral therapy
    Chitu-Tisu, Cristina Emilia
    Barbu, Ecaterina Constanta
    Lazar, Mihai
    Bojinca, Mihai
    Tudor, Ana-Maria
    Hristea, Adriana
    Abagiu, Adrian Octavian
    Ion, Daniela Adriana
    Badarau, Anca Ioana
    [J]. ACTA CLINICA BELGICA, 2017, 72 (01) : 55 - 62
  • [5] Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy
    Sevastianova, K
    Sutinen, J
    Westerbacka, J
    Ristola, M
    Yki-Järvinen, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 (08) : 925 - 935
  • [6] DYSLIPIDEMIAS IN HIV-INFECTED CHILDREN AND ADOLESCENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Mancao, M.
    Abesamis, A.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 380 - 380
  • [7] Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy
    Miller, TL
    [J]. AIDS, 2003, 17 : S130 - S140
  • [8] Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy
    Molia, AC
    Strady, C
    Rouger, C
    Beguinot, IM
    Berger, JL
    Trenque, TC
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2050 - 2054
  • [9] Subdinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy
    Calza, L
    Manfredi, R
    Chiodo, F
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 361 - 363
  • [10] Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy
    Risa, KJ
    Nepon, L
    Justis, JC
    Panwalker, A
    Berman, SM
    Cinti, S
    Wagener, MM
    Singh, N
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (10) : 706 - 713